|
|
|
|
|
|
Sponsors and Collaborators: |
University Hospital, Clermont-Ferrand Janssen-Cilag Farmaceutica Ltda. |
Information provided by: | University Hospital, Clermont-Ferrand |
ClinicalTrials.gov Identifier: | NCT00750529 |
The aim of the study is the analysis of two inhibitors of Ach-E: galantamine and donépézil in over 65 years' old patients suffering from Alzheimer disease (MMSE between 20 and 26) without Alzheimer's medication.
Condition | Intervention | Phase |
Alzheimer's Disease |
Drug: Galantamine and Donepezil |
Phase I |
Genetics Home Reference related topics: | Alzheimer disease |
MedlinePlus related topics: | Alzheimer's Disease |
ChemIDplus related topics: | Galantamine hydrobromide Galantamine Donepezil E 2020 |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Dose Comparison, Crossover Assignment, Pharmacodynamics Study |
Official Title: | Effects of Galantamine and Donépézil on the Amount and the Quality oh the Sleep in Patients Suffering From Alzheimer Disease. |
Estimated Enrollment: | 24 |
Study Start Date: | September 2008 |
Estimated Study Completion Date: | September 2009 |
Estimated Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |
Feasibility study, open, randomized, controlled, cross-over study in 65 years old patients.
Ages Eligible for Study: | 65 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Lacarin Patrick | 04.73.75.11.95 | placarin@chu-clermontferran.fr |
France | |||||
CPC-CIC | Not yet recruiting | ||||
Clermont-Ferrand, France, 63003 | |||||
Contact: Dubray Claude, Pr 04.73.17.84.10 cdubray@chu-clermontferrand.fr |
University Hospital, Clermont-Ferrand |
Janssen-Cilag Farmaceutica Ltda. |
Principal Investigator: | Dubray Claude, Pr | University Hospital, Clermont-Ferrand |
Responsible Party: | CIC CPC ( Pr Claude Dubray ) |
Study ID Numbers: | CHU-0038 |
First Received: | September 9, 2008 |
Last Updated: | September 19, 2008 |
ClinicalTrials.gov Identifier: | NCT00750529 |
Health Authority: | France: Ministry of Health |
|
|
|
|
|